Paid participation in clinical research has been common and controversial for years. Discussion in scholarly literature, in guidance and regulatory documents, and among investigators and institutional review board members has centered around concerns about impairing judgment, blinding subjects to risk, exploitation, commodification, or unjust distribution of research burden [1] . The article by Devine et al. [2] in this issue addresses a different and largely understudied concern -the potential for paid research subjects to misrepresent themselves in order to gain entry into studies.
These concerns have been recognized for some time. For example, concealment was at the core of the highly publicized death of Bernadette Gillcrist in 1980 [3, 4] . Gillcrist, a nursing student, enrolled in a paid sleep-deprivation study, but did not report her history of anorexia, self-induced vomiting, and cardiac arrest. She then died, likely from cardiac arrest secondary to electrolyte disturbance in the context of self-induced vomiting. Warnings of deception and fabrication have since appeared in the literature and in guidance documents, and the emergence of 'professional research subjects' has generated further attention to these issues.
This study helps to legitimate these concerns among experienced subjects. The fact that 75% of respondents reported some element of concealment is worrisome, as is the appreciable frequency of fabrication of health information (33% overall). Fabrication is obviously concerning, because false data involving important outcomes -whether subjects identify them as such or not -may directly affect the nature and impact of the findings generated.
This study also reveals an interesting organizational element that undergirds at least some of the deception taking place. The problem of simultaneous enrollment is well known, and many investigators are likely aware that experienced subjects know common exclusion criteria. However, the existence of 'research kingpins' and networks for sharing screening tips is eye-opening. This report does not identify how common these practices are, but the presence of organized efforts to skirt exclusion criteria raises the level of concern.
In fact, this study adds to other recent data in spurring a shift in thinking about the potential impact of money on enrollment decisions. In contrast to traditional concerns about blinding subjects to risk, for example, several recent studies have suggested that payment may not impair understanding and may actually sensitize potential participants to concerns about risk. Cryder et al. [5] demonstrated that higher payments correlated with increased time reading online study information and relatively higher rating of the riskiness of trial participation. Other studies have also suggested that increased amounts of money do not have outsized effects on enrollment willingness or diminish appreciation of risks [6, 7] . These studies, which have been used to support arguments that payment likely does not impair decisions [8] , interestingly cohere with the finding of Devine et al. of a positive correlation between deceptive practices and concern about risk. Taken together, it appears that deception may be a calculated practice undertaken by individuals with self-interested motives who are aware of and sensitive to risk as opposed to being blinded to or irrationally unconcerned with risk.
These data are thus consistent with a shift away from worries about compromised consent or justice issues and have interesting and important potential implications. The principal shift is toward greater emphasis on protection of scientific integrity as opposed to protection of subjects. Regardless of one's view of who bears ethical responsibility for harm to subjects that result from deception, these practices are indisputably problematic if they occur with significant frequency due to their scientific implications and their potential to jeopardize the research enterprise. In other words, deception is problematic regardless of one's views regarding traditional payment-related concerns.
While this study importantly influences discussions about recruitment practices, it has real limitations, as the authors recognize. First, these are not 'typical' research subjects. It is unknown how many subjects fall into the category of 'experienced subjects' or how differently they behave with regard to their willingness to misrepresent themselves to gain study entry. Related, this study does not clarify the range of studies for which deception concerns are most salient, though it does demonstrate that not all deception occurs among 'healthy' subjects. As the authors point out, these issues are almost certainly more likely to be of relevance when conditions are assessed by patient-reported or subjective metrics such as pain or psychiatric symptoms.
Second, these data do not reveal how often deception or concealment occurs; the survey only provided the number of types of deception and not the instances of deception. Given the large number of studies in which most participants reported participating, deception could still be quite rare. More importantly, the magnitude, gravity, or impact of deceptive practices could not be assessed. Embellishing seasonal allergy symptoms, for example, is entirely different from reporting fictitious suicidal ideation, though both could be categorized similarly in this study. In the hypothetical study by Bentley and Thacker [6] , for example, the relationship between increased likelihood of misrepresentation and higher payment was only present in lower risk scenarios. Whether these subjects only engaged in deception for lower risk studies is unknown. More detailed data about the type, frequency, and magnitude of deception, as well as their relevance to study endpoints and risks, are essential in order to assess the impact of and proper responses to these concerns.
Finally, this survey did not explicitly examine the relationship between deceptive practices and payment strategies. It is unknown whether higher payments lead to more deception, whether subjects fabricate side effects in order to get out of studies while still getting paid in full, and whether completion bonuses increase or reduce deception. Moreover, the effect of various payment strategies on enrollment itself is largely undefined.
Most directly, these data identify a need for further study. Additional observational research could characterize the nature and magnitude of these problems and clarify whether more aggressive monitoring or preventive strategies are warranted. Experimental designs could help to define the impact of different recruitment practices on both deception and enrollment. However, minimizing deception may turn out to be difficult. Clinical study registries have been proposed and implemented in some locations but are logistically challenging and may be limited in scope to Phase I research [9] . Objective monitoring may be useful but may not be possible for some conditions or outcomes. Relaxing inclusion criteria might increase the pool of eligible subjects and reduce pressures to deceive, but this could also reduce scientific integrity. Decreasing payment could minimize deception at the expense of recruitment.
The potential difficulty of combating these practices only reinforces the importance of further definition of the problem itself. These authors have helped to clarify the reality of an issue that has been discussed for years. One hopes that they and others will continue to define its scope, magnitude, and potential remedies through further work.
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